BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29622077)

  • 1. Dilemmas in Lung Cancer Staging.
    Vlahos I
    Radiol Clin North Am; 2018 May; 56(3):419-435. PubMed ID: 29622077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer.
    Kandathil A; Kay FU; Butt YM; Wachsmann JW; Subramaniam RM
    Radiographics; 2018; 38(7):2134-2149. PubMed ID: 30422775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
    Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
    Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging Lung Cancer: Metastasis.
    Shroff GS; Viswanathan C; Carter BW; Benveniste MF; Truong MT; Sabloff BS
    Radiol Clin North Am; 2018 May; 56(3):411-418. PubMed ID: 29622076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of Non-Small-Cell Lung Cancer.
    Akhurst T
    PET Clin; 2018 Jan; 13(1):1-10. PubMed ID: 29157380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Computed tomography imaging of non-small cell lung cancer].
    Chassagnon G; Bennani S; Revel MP
    Cancer Radiother; 2016 Oct; 20(6-7):694-8. PubMed ID: 27614518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT imaging in pre-therapeutic assessment of lung cancer.
    Beigelman-Aubry C; Dunet V; Brun AL
    Diagn Interv Imaging; 2016 Oct; 97(10):973-989. PubMed ID: 27687833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of non-small cell lung cancer using integrated PET/CT.
    Kligerman S; Digumarthy S
    AJR Am J Roentgenol; 2009 Nov; 193(5):1203-11. PubMed ID: 19843732
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer.
    Mac Manus MP
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):510-20. PubMed ID: 20927018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
    Harders SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard P; Hoejbjerg JA; Pilegaard HK; Hager H; Rehling M; Rasmussen F
    Cancer Imaging; 2014 Jun; 14(1):23. PubMed ID: 25608616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
    Antoch G; Stattaus J; Nemat AT; Marnitz S; Beyer T; Kuehl H; Bockisch A; Debatin JF; Freudenberg LS
    Radiology; 2003 Nov; 229(2):526-33. PubMed ID: 14512512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of positron emission tomography for lung cancer staging.
    Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
    Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Watch the weathercock: changes in re-staging 18F-FDG PET/CT scan predict the probability of relapse in locally advanced non-small cell lung cancer.
    Marquez-Medina D; Martin-Marco A; Popat S
    Clin Transl Oncol; 2016 Feb; 18(2):228-32. PubMed ID: 26203801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer.
    Allen TL; Kendi AT; Mitiek MO; Maddaus MA
    Semin Thorac Cardiovasc Surg; 2011; 23(1):43-50. PubMed ID: 21807298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT in the staging of the non-small-cell lung cancer.
    Chao F; Zhang H
    J Biomed Biotechnol; 2012; 2012():783739. PubMed ID: 22577296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT in non-small cell lung cancer staging-promises and problems.
    Devaraj A; Cook GJ; Hansell DM
    Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
    Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubio VE; Ramos Font C; Sánchez-Palencia Ramos A; Delgado Pérez JR; Llamas Elvira JM
    Rev Esp Med Nucl; 2011; 30(4):211-6. PubMed ID: 21514978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.
    Abramyuk A; Appold S; Zöphel K; Hietschold V; Baumann M; Abolmaali N
    Lung Cancer; 2012 Nov; 78(2):148-52. PubMed ID: 22922126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.